Higher anti‐tumour efficacy of platinum(IV) complex LA‐12 is associated with its ability to bypass M‐phase entry block induced in oxaliplatin‐treated human colon cancer cells

OBJECTIVES: Therapeutic potential of conventionally used platinum‐based drugs in treatment of colorectal tumours has been limited due to high incidence of tumour resistance to them and to their severe side effects. This evokes a search for more suitable anti‐cancer drugs. We have compared ability of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cell Prolif
Main Authors: Vondálová Blanářová, O., Jelínková, I., Hyršlová Vaculová, A., Sova, P., Hofmanová, J., Kozubík, A.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2013
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496914/
https://ncbi.nlm.nih.gov/pubmed/24118195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12061
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki